Checkout Temporarily Unavailable. We’re updating our secure payment system. You can still browse our research catalog. Thank you for your patience.

Peptide Compounds

AT1-S research overview

A synthetic research peptide supplied for laboratory investigation of receptor signaling and metabolic model systems.

FOR RESEARCH USE ONLY

This product is intended exclusively for laboratory research purposes. It is not intended for human or veterinary use, consumption, administration, diagnosis, treatment, prevention, or cure of any disease or condition.

Sequence
Synthetic long-acting research peptide
Molecular weight
4113.6 g/mol
CAS
910463-68-2
Research category
Peptide Compounds

Compound identity and classification

AT1-S is classified as: Synthetic research peptide.

AT1-S is a synthetic peptide supplied as a lyophilized research compound. Identity, molecular weight, and purity are confirmed against the batch analytical report published for each lot.

General research background

Laboratory work with this class of research peptides examines receptor engagement and signaling behavior in cell and rodent model systems. ATMI Labs makes no claim regarding outcomes in any system.

Molecular and biological pathways under investigation

Research designs generally characterize receptor binding and downstream signaling in cell-based assays, with potency and selectivity established per model system.

Areas of laboratory research

Reported laboratory work with this material clusters into the following areas. Listing an area describes where research activity exists, not an established result.

  • Receptor binding and signaling potency assays
  • Cell-culture models of metabolic signaling
  • Rodent model-system research
  • Comparative peptide pharmacology studies

Analytical documentation

ATMI Labs publishes the identity and purity documentation supplied for each released lot. Any purity figure shown comes from the report filed for that specific batch rather than from a general catalog claim.

Research limitations

Published work involving AT1-S is largely confined to in vitro systems and preclinical animal models. Findings in those systems do not establish effects in humans, and model-to-model variability in preparation, vehicle, and endpoint selection limits direct comparison between studies.

Analytical purity describes the material, not biological activity. Laboratories should design their own controls, and treat any pathway description as a hypothesis under investigation rather than an established result.

Handling and laboratory considerations

Lyophilized research materials are handled as temperature-sensitive laboratory chemicals. Storage temperature, reconstitution solvent, container choice, and stability windows are determined by the receiving laboratory's written protocol.

Every ATMI Labs lot is released with batch documentation so identity and purity figures used in a study can be traced back to the specific lot in hand.

  • Confirm the lot identifier on the vial label against the published quality record.
  • Record lot, strength, and receipt date in the laboratory inventory before use.
  • Follow institutional handling, labeling, and disposal procedures for research chemicals.

References and scientific sources

ATMI Labs does not summarize or reinterpret individual studies on this page. Laboratories designing work with this material are expected to consult the primary literature directly.

  • PubMed / MEDLINE (National Library of Medicine) for peer-reviewed primary literature.
  • PubChem and ChEMBL for chemical identity, structure, and physicochemical records.
  • UniProt for sequence and receptor/target annotation where a protein target applies.
  • The lot-specific quality record published by ATMI Labs for analytical identity and purity.

Research use scope

AT1-S supplied by ATMI Labs is sold exclusively for laboratory research and analytical purposes. It is not a drug, supplement, cosmetic, or food, and it is not intended for human or veterinary use.

Nothing on this page describes therapeutic use, dosing, or clinical outcomes. Literature referenced in general terms describes laboratory and preclinical model systems only.

Lab specifications, released lots, and availability for this compound live on its catalog page.

More research overviews